Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revealix is a digital health company dedicated to the early detection and prevention of diabetic foot complications. The company's core technology utilizes mobile-based thermal imaging and computer vision to identify early signs of inflammation and tissue stress before they progress to clinical ulcers. By providing clinicians and patients with objective, actionable data, Revealix aims to reduce the incidence of amputations and lower the high costs associated with diabetic foot care. Their solution integrates seamlessly into clinical workflows, enabling remote monitoring and proactive intervention for high-risk diabetic populations. The platform focuses on the 'at-risk' foot, shifting the paradigm from reactive wound treatment to proactive limb preservation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revealix.